Page last updated: 2024-08-22

floxacillin and oritavancin

floxacillin has been researched along with oritavancin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Falla, E; Mantopoulos, T; Nathwani, D; Vlachaki, I; Zinzi, D	1

Other Studies

1 other study(ies) available for floxacillin and oritavancin

Article	Year
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. The European journal of health economics : HEPAC : health economics in prevention and care, 2022, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin	2022

Article

Year

Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective.

The European journal of health economics : HEPAC : health economics in prevention and care, 2022, Volume: 23, Issue:8

Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin

2022